Browse Articles

Discover research articles across all indexed journals

Spatial distribution of uptake of newly introduced vaccines and its associated factors among children aged 12–35 months in Ethiopia: Multi-scale Geographically Weighted Regression Analysis

PLoS ONE Habtamu Guaguahu Feleke, Mulat Belay Simegn, Daniel Tarekegn Worede et al. Jul 02, 2026 DOI: 10.1371/journal.pone.0345899

Background The pneumococcal conjugate vaccine (PCV) and rotavirus vaccine (RVV) have been introduced to Ethiopia’s expanded childhood immunization program in 2011 and 2013, respectively. Methods A cross-sectional study among 2,055 children aged 12–35 months was employed. Data were extracted from the Kids Record file of the 2019 Ethiopian Mini Demographic and Health Survey. Spatial regression models were fitted and compared using corrected Akaike Information Criteria, Bayesian Information Criteria and adjusted R 2 . Spatial predictors were determined to be statistically significant if their p-value was < 0.05. Results Incomplete uptake of recently introduced immunizations was observed in nearly half (48.83%) of children aged 12–35 months. Its distribution throughout Ethiopia’s regions shows significant spatial clustering, with the eastern part of SNNPR and Somali regions having hot spots. A total of 3 significant clusters, located in southern Oromia, east and west Hararge, the entire SNNPR, and the majority of the Somali region, with a high rate of incomplete uptake of newly introduced vaccines, were identified during SaTScan analysis. Not having vaccination cards, household size more than 5 members, home delivery, not having postnatal care, and less than 18 maternal age at first birth are positive significant spatial factors while parents not being head of the household were identified as negative significant spatial factors. Conclusion There is high incomplete uptake and spatial disparities of PCV and RVV. To improve vaccination coverage among children aged 12–35 months, policymakers and health planners should prioritize targeted interventions in hotspot areas, strengthen maternal health service utilization, and enhance vaccination tracking systems. Promoting community awareness and improving access to essential health services will be critical to ensuring equitable immunization uptake across the country.

Ferric carboxymaltose increases fracture risk in patients and reduces bone formation in mice with iron deficiency anemia

Blood Sonja A. Wagner, Marlene Panzer, Elke Pertler et al. Jul 02, 2026 DOI: 10.1182/blood.2025031806

Abstract Modern IV iron formulations allow treatment of iron deficiency anemia (IDA) with 1 or 2 infusions. Ferric carboxymaltose (FCM) is a widely used IV iron, which causes hypophosphatemia in most of the patients. Osteomalacia and fractures are increasingly recognized after repeated infusions of FCM. It is unknown why ferric derisomaltose (FDI) rarely causes hypophosphatemia. In this study, we compare the effects of FCM and FDI on fracture risk and investigate potential underlying mechanisms explaining the different effects on bone and mineral metabolism. For this aim, fracture rate and osteomalacia were assessed in a cohort of 357 patients treated with either drug, who reported a significantly higher rate of incident osteomalacia or fracture after FCM. These findings were validated in >20 000 patients from the TriNetX database, where FCM treatment was independently associated with a higher fracture risk compared with FDI. The underlying mechanisms were investigated in a mouse model of IDA treated with FCM or FDI, an osteocyte model, and biochemically. FCM caused lower expression of collagen and ossification genes, associated with significantly higher bone iron concentrations than FDI. Electron microscopy showed iron-loaded vesicles in osteoblasts and early osteocytes. FCM but not FDI inhibited the binding of dentin matrix protein 1 to αVβ3-integrin on osteocytes. This is a potential mechanism for reduced bone formation and higher levels of intact fibroblast growth factor 23 after FCM. Our data report that IDA and FCM treatment can directly impair bone formation and increase fracture risk.

Research on the impact of green dynamic capability and corporate green transformation–based on the moderating role of ESG management

Scientific Reports Lei Xi, Xiayu Li Jul 02, 2026 DOI: 10.1038/s41598-026-60764-8

Prokaryotic Schlafen proteins cleave tRNAs during type III CRISPR immunity

Nature Communications Pedro Weickert, Yang Liu, Jonathan Strecker Jul 02, 2026 DOI: 10.1038/s41467-026-74880-6

Association of urinary post-translationally modified fetuin-A fragments with diabetic kidney disease risk stratification in Japanese patients with type 2 diabetes

PLoS ONE Toshiko Mori, Hiroyuki Ito, Taiki Kozasa et al. Jul 02, 2026 DOI: 10.1371/journal.pone.0353032

Aims Conventional biomarkers such as estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (uACR) primarily reflect glomerular damage and often fail to detect early tubular injury. Consequently, patients with “non-albuminuric diabetic kidney disease (DKD)” may be overlooked. This study evaluated the independent association between urinary post-translationally modified fetuin-A fragments (uPTM-FetA) and DKD risk stratification in Japanese patients with type 2 diabetes. Methods We conducted a cross-sectional study of 219 outpatients with type 2 diabetes between November 2023 and February 2024 at Edogawa Hospital. First-morning urine samples were analyzed for uPTM-FetA and urinary liver-type fatty acid-binding protein (uL-FABP) using enzyme-linked immunosorbent assays. DKD risk was classified into four categories based on the KDIGO guidelines. The association between uPTM-FetA and higher DKD-risk (categories 2 + 3 + 4) was assessed using multiple logistic regression and restricted cubic spline (RCS) analyses, validated by bootstrapping. Results The optimal cutoff value for uPTM-FetA was determined to be 11.76 ng/mgCr. Multivariable analysis adjusted for potential confounders revealed that high uPTM-FetA levels were significantly and independently associated with DKD-risk categories 2 + 3 + 4 (adjusted odds ratio: 3.88; 95% CI: 2.02–7.45; P < 0.01). RCS analysis indicated a significant non-linear association (P = 0.04). Notably, high uPTM-FetA was detected in 38.8% of patients with normoalbuminuria and 42.0% of those with preserved eGFR. A striking discrepancy was observed compared to uL-FABP: while high uL-FABP was completely absent (0.0%) in patients within the low-to-moderate risk categories (categories 1 and 2), high uPTM-FetA was observed in 34.0% and 60.8% of these patients, respectively. Conclusions uPTM-FetA is independently associated with DKD severity and is elevated in a substantial proportion of patients with early-stage disease where conventional markers remain normal. Unlike uL-FABP, which increases predominantly in advanced stages, uPTM-FetA appears to identify tubular stress earlier. Thus, uPTM-FetA serves as a valuable complementary biomarker to uACR for refining DKD risk stratification.

Is low a go for pediatric AML?

Blood Rishi S. Kotecha Jul 02, 2026 DOI: 10.1182/blood.2026033776

Triglyceride/HDL-cholesterol ratio as a predictor for treatment-related severe hypertriglyceridemia in children with lymphoid malignancies

Scientific Reports Anna Małecka, Ninela Irga-Jaworska, Ewa Wieczorek-Breitzke et al. Jul 02, 2026 DOI: 10.1038/s41598-026-59133-2

Modulation of intra-oceanic trench bending and along-trench thermochemical transport by mantle toroidal flow

Nature Communications Liang Liu, Zebin Cao, Jason P. Morgan et al. Jul 02, 2026 DOI: 10.1038/s41467-026-75061-1

Toward evidence-based prescription of prosthetic ankle-foot devices: A multisite randomized crossover trial identifying performance-based, patient-reported, and biomechanical parameters sensitive to device type

PLoS ONE Jason T. Maikos, Alexis N. Sidiropoulos, John M. Chomack et al. Jul 02, 2026 DOI: 10.1371/journal.pone.0352644

Prescription of prosthetic ankle-foot devices is constrained by imprecise clinical guidelines and inconsistent scientific evidence, hindering optimal device selection for individuals with lower limb loss. This multisite, prospective, randomized crossover study aimed to identify patient-reported, performance-based, and biomechanical parameters sensitive to ankle-foot device type, providing a foundation for more objective and individualized prescription practices. Ninety-one individuals with unilateral transtibial limb loss completed the crossover trial, and 13 control participants without musculoskeletal impairment were enrolled to provide normative reference data. Participants were fitted with duplicate sockets and randomized to trial three ankle-foot device types: energy storing and returning, articulating, and powered. Participants were heterogeneous in demographic characteristics, including veterans, service members, and civilians. After one week of acclimation per device, participants completed performance-based (6-minute walk, Timed Up and Go, Four Square Step Test, Stair and Hill Assessment Indices, Amputee Mobility Predictor) and patient-reported (Prosthesis Evaluation Questionnaire, 12-Item Short Form Health Survey, Orthotics and Prosthetics Users’ Survey) assessments; a subset (n = 29 completed) underwent full-body gait analysis to capture detailed biomechanical parameters. Biomechanical outcomes demonstrated the greatest sensitivity to device type, with 19 distinct parameters, primarily at the ankle, highlighting ankle mechanics as a key determinant of differences among prosthetic devices. Five Prosthesis Evaluation Questionnaire subscales were sensitive to device type, while performance-based measures showed no significant effects. Results revealed a dichotomy between biomechanical and patient-reported outcomes: Biomechanical parameters were more similar to control values for powered devices, whereas patient-reported outcomes favored non-powered devices. Linear discriminant analysis identified key gait features, including peak plantarflexion during preswing and peak ankle moment, which most strongly contributed to group separation and clinical discrimination. These findings identified distinct biomechanical and patient-reported parameters sensitive to ankle-foot device type and highlight the need for evidence-based, individualized prosthetic prescription to optimize device selection and improve patient outcomes.

EBV and immunodeficiency: the odd couple drawn to the brain

Blood Andrés J. M. Ferreri Jul 02, 2026 DOI: 10.1182/blood.2026033838

Energy transfer and dynamic response of a gasbag-driven confined granular bed

Scientific Reports Jinwei Wang, Jingjing Hou, Chunlei Jiang et al. Jul 02, 2026 DOI: 10.1038/s41598-026-59581-w

BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistance

Nature Communications Soo-Yeon Hwang, Xiangao Huang, Helgi Nikolli et al. Jul 02, 2026 DOI: 10.1038/s41467-026-75123-4

Abstract Resistance to Bruton’s tyrosine kinase inhibitors (BTKi) remains a major therapeutic challenge in B-cell malignancies. Here, we identify chromatin remodeler BRG1-mediated suppression of ferroptosis as a central mechanism of BTKi resistance in mantle cell lymphoma (MCL), in which aberrant BRG1-dependent transcription program protects cells from BTKi-induced ferroptosis by restricting reactive oxygen species (ROS) and labile iron. Mechanistically, BRG1 promotes resistance through regulation of both BTK-dependent survival signaling and a BTK-independent transcriptional program. The latter is mediated by BRG1-driven induction of MEF2B, which upregulates atypical mitochondrial complex I subunit NDUFA4L2. Increased NDUFA4L2 restricts cellular respiration, preemptively limiting mitochondrial ROS generation and activating AMPK signaling, together reducing susceptibility to lipid peroxidation and ferroptosis. Pharmacologic inhibition of BRG1 disrupts these programs, restoring ferroptotic sensitivity and synergizing with BTKi across resistant MCL models. Together, our study establishes BRG1 as a central regulator of BTKi resistance and provides a rationale for co-targeting BRG1 and BTK as a therapeutic strategy for B-cell malignancies.

OncoSeg2D: A deep framework for semantic segmentation of lung cancer in 2D CT scans

PLoS ONE Luhang Yu, Xueshan Dong, Kai Fa et al. Jul 02, 2026 DOI: 10.1371/journal.pone.0348719

Lung cancer lesion segmentation in two-dimensional computed tomography (2D CT) images remains challenging due to blurred boundaries, heterogeneous morphologies, and annotation uncertainty, leading to unreliable delineations and reduced clinical usability. To address this research gap, we propose a novel 2D CT lung cancer semantic segmentation framework, OncoSeg2D, which explicitly tackles boundary ambiguity and morphological distortion through two complementary modules. Specifically, an Uncertainty-aware Boundary Modeling (UBM) module probabilistically represents tumor edges via learnable mean–variance estimation and gradient-weighted sampling, while a Morphology-Preserving Regularization (MPR) module constrains the segmentation with curvature, compactness, and convexity priors to maintain global shape consistency. The framework integrates these designs with multi-scale feature extraction from a SegFormer backbone and requires no additional annotations or three-dimensional (3D) reconstruction. Experiments conducted on the Medical Segmentation Decathlon Challenge dataset and the lung cancer segmentation dataset demonstrate that OncoSeg2D achieves IoU scores of 0.865 and 0.788, mIoU scores of 0.881 and 0.799, and Dice Similarity Coefficients (DSC) of 0.923 and 0.816, consistently outperforming conventional CNN-based models and mainstream Transformer-based methods. Compared with the SegFormer baseline, the proposed method improves mIoU by 3.8% and 4.0% on the two datasets, respectively, while reducing the Hausdorff distance from 5.61 to 3.41 and from 7.26 to 5.28, indicating superior boundary refinement and stronger global shape consistency. These results verify that explicitly integrating uncertainty modeling and morphological priors yields both higher accuracy and better interpretability. Overall, the proposed framework not only enhances segmentation accuracy but also improves clinical interpretability and reliability, offering a promising solution for lung cancer diagnosis assistance and therapeutic outcome monitoring.

CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD

Blood Zengkai Pan, Yujun Deng, Jingtao Huang et al. Jul 02, 2026 DOI: 10.1182/blood.2025032587

Abstract Steroid-refractory (SR) disease develops in a substantial fraction of patients with grade II to IV acute graft-versus-host disease (aGVHD) and is associated with poor long-term survival. Improved mechanistic insight is needed to identify reliable predictors of steroid resistance. We retrospectively profiled peripheral blood collected before glucocorticoid treatment from allogeneic hematopoietic cell transplantation recipients without aGVHD, with steroid-sensitive aGVHD, and with SR-aGVHD using an integrated multiomics approach, and validated our findings in an independent multicenter cohort. Mass cytometry revealed an expansion of activated CD28+ CD8+ effector-memory T (Tem) cells in SR-aGVHD. Absolute counts of these cells at neutrophil engraftment predicted subsequent steroid resistance in the multicenter cohort and performed comparably to established clinical classifiers. This phenotype was associated with a proinflammatory milieu enriched in interleukin-2 (IL-2), IL-27, and interferon gamma. Single-cell RNA sequencing and functional assays implicated a STAT1–glucocorticoid receptor (GR) regulatory axis, in which inflammatory cytokines induce STAT1 phosphorylation and suppress GR expression, consistent with intrinsic glucocorticoid resistance. JAK inhibition rescued cytokine-induced steroid resistance in vitro, whereas in patients with SR-aGVHD, clinical response to ruxolitinib was accompanied by reduced STAT1 activation, restoration of GR expression, and contraction of the expanded CD8+ Tem cell pool. These findings identify immune dysregulation in SR-aGVHD centered on CD8+ Tem cells with a STAT1-dependent GR deficit and support a mechanistic link to steroid refractoriness. CD28+ CD8+ Tem cell counts may serve as a biomarker of SR-aGVHD and inform the development of preemptive, pathway-targeted therapeutic strategies.

Correlation of dielectrophoretic crossover frequency with optical density and plate counts for assessing Staphylococcus aureus concentration analysis

Scientific Reports Arash Zulkarnain, Akmal Suhaimi, Abdullah Abdulhameed et al. Jul 02, 2026 DOI: 10.1038/s41598-026-59587-4

Sulfur-passivated Pt cluster edges on CeO2 for selective CO2-to-CO conversion

Nature Communications Jiwei Lei, Zihe Wu, Daoping Ye et al. Jul 02, 2026 DOI: 10.1038/s41467-026-75184-5

Spontaneous passage of common bile duct stones: predictive factors and impact on post-ERCP complications

PLoS ONE Wasuwit Wanchaitanawong, Phichayut Phinyo, Thanaput Kunlayawutipong et al. Jul 02, 2026 DOI: 10.1371/journal.pone.0351242

Background Spontaneous passage of common bile duct stones (CBDSs) may render endoscopic retrograde cholangiopancreatography (ERCP) unnecessary. Although predictors of passage have been described, most prior studies were limited by a small number of events, and the impact of spontaneous passage on post-ERCP complications remains under-investigated. This study aimed to identify clinical predictors of spontaneous passage and evaluate its association with post-ERCP complications. Methods We conducted a retrospective cohort study of patients diagnosed with CBDSs who underwent endoscopic ultrasonography (EUS) or ERCP at a tertiary referral center. Spontaneous passage was defined as the absence of stones confirmed during the procedure. Multivariable risk regression was used to identify predictors of passage and to assess the association between spontaneous passage and post-ERCP complications. Results Spontaneous passage was observed in 113 of 404 patients (28%). Independent predictors of spontaneous passage included younger age (RR 0.88 per 10 years; 95% CI 0.81–0.96), smaller CBDS size (RR 0.78 per 1 mm; 95% CI 0.71–0.85), and single CBDS (RR 1.64; 95% CI 1.04–2.61). Regarding complications, post-ERCP pancreatitis (PEP) occurred more frequently in patients with spontaneous passage compared to those without (16.5% vs 7.6%, P = 0.01). After adjusting for relevant confounders, including procedural factors, spontaneous passage remained an independent risk factor for PEP (RR 2.48, 95% CI 1.25–4.92). Conclusions Spontaneous passage of CBDSs is an independent risk factor for PEP. Younger age, smaller stone size, and a single stone are significant predictors of passage. These findings suggest that pre-procedural risk stratification and non-invasive confirmation of ductal clearance may be beneficial in selecting appropriate candidates, potentially reducing unnecessary ERCP and associated complications.

ELISA-negative HIT: antibody recognition and relevance

Blood Andreas Greinacher, Thomas Thiele Jul 02, 2026 DOI: 10.1182/blood.2026034332

An intelligent embedded fuzzy genetic classifier based network intrusion detection system for secured communication in internet of things

Scientific Reports Muneer M A, A. Ayyasamy, L. Sridhara Rao Jul 02, 2026 DOI: 10.1038/s41598-026-59261-9

Abstract Internet of things (IoT) is a distributed connection of smart objects which collects the data or information from the deployed environment and communicates the data to other devices with Internet as a backbone. Due to its unfriendly deployment nature and openness in communication via Internet, IoT is vulnerable to various types of attacks during data transmission. Intrusion Detection System (IDS) is an effective method to provide strong and efficient security to IoT devices. IDS is a software that tracks the network traffic and identifies the anomalies and abnormal activities. An Improved Ant Colony Optimization (IACO) algorithm with mutual information is proposed which effectively identifies the features in the given dataset and ranks. Moreover, for classification a Hybrid Fuzzy Genetic Algorithm (HFGA) is proposed to identify various types of attacks in the network. The proposed classifier comprises two layers namely external and internal. The external layer generates fuzzy sets and internal layer generates fuzzy rules. In the proposed system during training phase the External Fuzzy Genetic Algorithm (EFGA) helps Internal Fuzzy Genetic Algorithm (IFGA) and the finest individual from EFGA is associated with the fragile individual from IFGA to produce a new output which enhances the estimation of mutated attacks. The performance of the proposed system is evaluated using NSL-KDD dataset. Most of the existing IDS in IoT suffers from lower Intrusion detection accuracy, false alarm rate and has high computational and communication overhead. From the result, the proposed system has achieved better intrusion accuracy and reduced the false alarm rate in the network. Moreover, the proposed system identifies both known attacks and unknown attacks in the network.

Macrophage INSIG1 deficiency drives psoriasiform dermatitis via the SREBP2-STAT1 axis

Nature Communications Xiangzheng Li, Yu Zang, Xi Li et al. Jul 02, 2026 DOI: 10.1038/s41467-026-73278-8